Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

P.A. Cascales-Campos,V. López-López,J. Torres Melero,A. Arjona,F.C. Muñoz-Casares,P. Barrios,R. Morales,F. Pereira,P Bretcha Boix,L. Gonzalez-Bayon,Santiago González Moreno,J. Gil

Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP)

2019

P.A. Cascales-Campos
V. López-López
J. Torres Melero
A. Arjona
F.C. Muñoz-Casares
P. Barrios
R. Morales
F. Pereira
P Bretcha Boix
L. Gonzalez-Bayon
Santiago González Moreno
J. Gil

Background The attitude toward cytoreductive surgery with HIPEC in peritoneal carcinomatosis from colorectal cancer is unclear. The aim of this study is to report the perioperative outcomes after cytoreductive surgery with HIPEC in patients ≥ 75 years.

Keywords:

Hyperthermic intraperitoneal chemotherapy
General surgery
Colorectal cancer
Medicine
Peritoneal cancer
Perioperative
Surgery
in patient
multicenter study
peritoneal carcinomatosis
cytoreductive surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations